Novel neutralizing SARS-CoV-2-specific mAbs offer detection of RBD linear epitopes

Table 2 Characterization of anti-rRBD monoclonal antibodies

mAb (clone)	Reactivity assessment with prokaryotic rRBD by ELISA	Reactivity assessment with eukaryotic RBD by ELISA	Neutralization with prokaryotic rRBD by blocking ELISA	Neutralization with blocking eukaryotic RBD by ELISA	Reactivity assessment with prokaryotic rRBD by western blot
2B4-G11	2 +	2 +	2 +	Neg	Neg
1D9-D1	2 +	2 +	2 +	Neg	Neg
1G1-G9	3 +	3 +	4 +	Neg	Pos (2 +)
2E7-D2	4 +	4 +	4 +	2 +	Pos (2 +)
2B4-G8	4 +	4 +	4 +	2 +	Pos (4 +)

^*The reactivity was presented as (Neg Negative reactivity, 1 + : Weak reactivity, 2 + : Moderate reactivity, 3 + : Strong reactivity, and 4 + : Very strong reactivity)

ISSN: 1743-422X